Arm Shares Rose Amid Qualcomm Federal Trial

Shares gained against the broader market index as a Delaware trial over licensing agreements entered its first week.

Updated on Oct. 13, 2026 in Semiconductors

Isometric editorial illustration showing a layered silicon wafer stack and a metal bracket, representing the structural nature of semiconductor industry licensing.
Arm Holdings shares rose 0.94% on Monday as a federal trial in Delaware began regarding Qualcomm's claims of breached licensing agreements. AI Illustration. Upload story photo >

Live Poll

Do you think now is a good time to invest in companies heavily focused on AI?

Arm Holdings stock increased 0.94% to $257.65 on October 13, 2026, even as broader indices like the Nasdaq and S&P 500 posted daily losses. The movement follows the commencement of a federal trial in Delaware where Qualcomm alleges that Arm breached licensing agreements.

Why it matters

The trial addresses the stability of the long-term licensing relationships that underpin much of the semiconductor industry. Its outcome could impact future collaborations on AI-ready hardware as the U.S. prepares for an estimated $10.3 trillion infrastructure buildout through 2032.

Arm shares closed at $257.65, trading significantly above the 200-day simple moving average of $221.53 but below the 50-day average of $270.41 and 20-day average of $290.20. The current price remains within the 52-week range of $100.02 and $452.70.

The players

Arm Holdings

A semiconductor design company that provides the fundamental instruction set architecture for most mobile and low-power processors.

Qualcomm

A developer of wireless telecommunications hardware and system-on-chip products for the mobile and automotive sectors.

Meta Platforms

A technology conglomerate focused on social media, artificial intelligence, and hardware platforms like Quest.

The details

The legal dispute centers on allegations that Arm sabotaged Qualcomm’s strategic dealings with Meta Platforms. Qualcomm contends these actions violate established licensing agreements that allow for the development of custom architecture. The trial in Wilmington is currently scheduled to proceed over five days of testimony.

Timeline

  1. February 2026: ARM set its 52-week low.

  2. April 2026: A Golden Cross occurred for ARM stock.

  3. June 2026: ARM set its 52-week high.

  4. October 9, 2026: A Delaware jury received Qualcomm's lawsuit against Arm.

  5. October 13, 2026: ARM stock rose 0.94 percent.

The Tech Race

The current litigation marks a critical point of friction in the semiconductor industry's ecosystem. This dispute highlights the fragility of licensing dependencies that drive the development of high-performance AI infrastructure.

Qualcomm’s architecture license with Arm remains active through 2033, meaning current product roadmaps and existing hardware remain unaffected by the proceedings. The trial primarily serves as a bellwether for how future high-stakes licensing disputes may be adjudicated in federal court.

The takeaway

The trajectory of this stock movement remains tethered to the five-day trial in Delaware. Investors and engineers should monitor the court's final assessment of the licensing breach allegations, as this outcome will likely set a benchmark for future intellectual property disputes.

Further reading

For more on the industry trends shaping these legal shifts, see the latest updates in Semiconductors.

Source note: This article includes information reported by Benzinga.

Live Poll

Do you think now is a good time to invest in companies heavily focused on AI?